Evidence map›Paper›PMID 26404731›Full record

ArticleExperimental cell research2016

Dot1l deficiency leads to increased intercalated cells and upregulation of V-ATPase B1 in mice.

Zhou Xiao, Lihe Chen, Qiaoling Zhou, Wenzheng Zhang

Abstract read
In one paragraph

Article in Experimental cell research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. A novel role of DOT1L in kidney diseases.Molecular biology reports · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Development and Diseases of the Collecting Duct System.Results and problems in cell differentiation
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Zhou XiaoDepartment of Internal Medicine, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China; Department of Internal Medicine, University of Texas Medical School at Houston, Houston, TX 77030, USA.
Lihe ChenGraduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Qiaoling ZhouDepartment of Internal Medicine, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China.
Wenzheng ZhangDepartment of Internal Medicine, University of Texas Medical School at Houston, Houston, TX 77030, USA; Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX 77030, USA. Electronic address: Wenzheng.zhang@uth.tmc.edu.
The University of Texas Health Science Center at Houston · USCentral South University · CNXiangya Hospital Central South University · CN

Funding

Epigenic Control of ENaC Transcription and Sodium TransportR01DK080236 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ZHANG, WENZHENG · 2009 to 2016
$2.2M
A novel urinary biomarker of diabetic nephropathyR21DK104073 · NIDDK · ALBANY MEDICAL COLLEGE · PI ZHANG, WENZHENG · 2015 to 2016
$435k
NIDDK NIH HHS R01 DK080236NIDDK NIH HHS R21 DK104073
6 · The paper itself

Abstract

The collecting duct in the mammalian kidney consists of principal cells (PCs) and intercalated cells (ICs), which regulate electrolyte/fluid and acid/base balance, respectively. The epigenetic regulators of PC and IC differentiation remain obscure. We previously used Aqp2 and V-ATPase B1B2 to label PCs and ICs, respectively. We found that mice with histone H3 K79 methyltransferase Dot1l disrupted in Aqp2-expressing cells (Dot1l(AC)) vs. Dot1l(f/f) possessed ~20% more ICs coupled with a similar decrease in PCs. Here, we performed multiple double immunofluorescence staining using various PC and IC markers and confirmed that this finding. Both α-IC and β-IC populations were significantly expanded in Dot1l(AC) vs. Dot1l(f/f). These changes are associated with significantly upregulated V-ATPase B1 and B2, but not Aqp2, AE1, and Pendrin. Chromatin immunoprecipitation assay unveiled a significant reduction of Dot1l and H3K79 di-methylation bound at the Atp6v1b1 5' flanking region. Overexpression of Dot1a significantly downregulated a stably-transfected luciferase reporter driven by the Atp6v1b1 promoter in IMCD3 cells. This downregulation was impaired, but not completely abolished when a methyltransferase-dead mutant was overexpressed. Taken together, our data suggest that Dot1l is a new epigenetic regulator of PC and IC differentiation and Atp6v1b1 is a new transcriptional target of Dot1l.

Indexed as

Up-RegulationAnimalsAnion Exchange Protein 1, ErythrocyteAquaporin 2Aquaporin 3Down-RegulationFluorescent Antibody TechniqueHistone-Lysine N-MethyltransferaseHistonesKidneyLysineMethylationMethyltransferasesMicePromoter Regions, GeneticRNA, MessengerAnion Exchange Protein 1, ErythrocyteAquaporin 2Aquaporin 3Atp6v1b1 protein, mouseDot1l protein, mouseHistone-Lysine N-MethyltransferaseHistonesLysineMethyltransferasesRNA, MessengerVacuolar Proton-Translocating ATPasesConditional knockoutHistone methyltransferase Dot1lIntercalated cellsPrincipal cellsV-ATPase

Identifiers

PMID26404731
PMCPMC5715659
OpenAlexW2103079247

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.